Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
about
Vesicular monoamine transporter 2: role as a novel target for drug developmentLobeline effects on tonic and methamphetamine-induced dopamine releaseThe effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in ratsDefunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporterComputational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats.The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseLobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.Lobeline Effects on Cognitive Performance in Adult ADHD.The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Dose-dependent attenuation of heroin self-administration with lobeline.Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.Phenyl ring-substituted lobelane analogs: inhibition of [³H]dopamine uptake at the vesicular monoamine transporter-2Treatment of Methamphetamine Cravings With Bupropion: A Case ReportIncreased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityThe effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2Antiepileptic activity of lobeline isolated from the leaf of Lobelia nicotianaefolia and its effect on brain GABA level in miceNovel medications to treat addictive disordersLobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration.Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivoLobeline attenuates progressive ratio breakpoint scores for intracranial self-stimulation in rats.Diet-induced obesity: dopamine transporter function, impulsivity and motivation.Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats.Methamphetamine-like discriminative-stimulus effects of nicotinic agonistsMembrane transporters as mediators of synaptic dopamine dynamics: implications for disease.Lobelane analogues as novel ligands for the vesicular monoamine transporter-2.Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptake.Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands.Exploring the effect of N-substitution in nor-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuse.1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2.Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats.Pyrrolidine analogs of GZ-793A: synthesis and evaluation as inhibitors of the vesicular monoamine transporter-2 (VMAT2).
P2860
Q24647764-A0F90104-3196-4646-8F2C-3CF68D55C1E9Q28264438-4147BAB8-E34A-47D2-B741-6413706DB075Q28267531-190B7F70-628D-4B76-A357-EF1EE999A8DFQ28267727-ACE607BF-A1AF-4C26-A44C-CE6D7D11490AQ28290902-DA031092-A406-419D-8E74-058D19D49DB6Q30478324-B5A28955-3F2E-4610-9647-F8DACDC37BF6Q30497495-D9B7192D-86CF-41C5-B428-A7909D002E01Q30498938-AC86D88C-DB5F-469D-B97D-4E8033C7CE7DQ33613631-573EEF72-79A0-47EF-AC5D-5067719201EEQ33738102-77498402-FF12-4939-8D87-79B2B88B4269Q33774323-36267965-E80E-4324-BF2E-C59FDB05337DQ33854736-DAA83897-FE5E-41FA-9F82-A0EE48D0942FQ33958021-1F9229F3-43BB-474F-87B1-BA3B57C89435Q34202539-3EC81E17-1D18-4173-B124-292CEB0ED704Q34702317-3F9CE9F7-C2FA-4FB5-8D1D-70AB5AF95EFAQ35666633-71A8A770-F662-42E8-BCED-11519149F982Q35810975-5A3DB47B-9E0E-4293-86BC-A9083F52D52DQ36079830-3642991C-9934-4A1B-B8D1-DEDA560B3275Q36103932-764E5266-DD3E-44DC-9BF4-75AEB5FF837DQ36719819-35943416-D05B-474F-B5F4-3E042BEAFD27Q37029633-AEA61F58-8AAE-4AF5-BDA8-E3E695FB5D79Q37052442-685D0B26-7AC5-4F3C-A275-D209D9E5896AQ37190441-5CC50A77-2D40-49FE-86ED-23DFB4133677Q37227997-3D2664DB-66EC-4153-90FF-5381F1E1DBF2Q37339533-6DFE4C54-9FF6-43B1-B61E-B5C947546315Q37376829-45004751-13F5-4EAC-BED7-41EB1A09546AQ37396979-31E82D29-817C-4AB8-8B04-B51BC260233CQ37603896-EDF61947-C5E5-4F9F-86D1-8F2E285F0EEDQ38926644-4B903918-7026-4418-8FA9-9810C36204E8Q41376925-E3F9DDBF-0D7D-4AAE-8FE5-0A19BBD35A27Q41916645-384CE2DA-4C72-4B02-A314-521E7075C9F0Q42033627-6AFD9F1D-5F63-4498-AF4A-ADB1F1B47FF6Q42098885-8F862D6A-AB0B-4A00-9DE6-A8A992F8784CQ42418144-DF0147F5-5235-4DF2-816C-262782C29852Q42682103-8846EA84-788D-4CEE-8ABC-182990C01594Q42864716-9224417C-235B-433D-A640-4B11146EA094Q43070321-926A3CD3-762E-4CD6-A395-B61316BBA7D8
P2860
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
@ast
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
@en
type
label
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
@ast
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
@en
prefLabel
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
@ast
Lobeline inhibits the neurochemical and behavioral effects of amphetamine.
@en
P2093
P1476
Lobeline inhibits the neurochemical and behavioral effects of amphetamine
@en
P2093
Dwoskin LP
Goldberg SR
P304
P407
P577
2001-03-01T00:00:00Z